FIELD: medicine.
SUBSTANCE: echocardiographic examination is conducted. Duration of the delayed ejection from the aorta (aortic pre-exposure period duration) is determined. Also, the patient's age in years and the level of NT-proBNP in ng/l in blood are determined. Based on the data obtained, the value of function F is determined according to the claimed formula. Further, a super response is predicted for cardiac resynchronization therapy (P). At a value of P less than 0.5, non-super-responders group is determined. At a value of P greater than 0.5, super-responders group is determined, and a super response to the cardiac resynchronization therapy is predicted.
EFFECT: method allows to increase the effectiveness of treatment of patients with chronic heart failure, to improve the selection of patients for implantation of devices for cardiac resynchronization therapy, due to evaluation of the most significant indicators.
1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTING SUPER-LIGHT ON A CARDIAC RESYNCHRONISING THERAPY IN PATIENTS WITH CHRONIC HEART FAILURE | 2019 |
|
RU2746530C2 |
| METHOD FOR PREDICTION OF RESPONSE TO CARDIAC RESYNCHRONISING THERAPY IN PATIENTS WITH CHRONIC HEART FAILURE | 2018 |
|
RU2716479C1 |
| METHOD FOR OPTIMISING ATRIOVENTRICULAR DELAY IN PATIENTS WITH CARDIAC RESYNCHRONISING THERAPY | 2014 |
|
RU2551636C1 |
| METHOD OF PREDICTING “SUPER RESPONSE” TO CARDIAC RESYNCHRONIZATION THERAPY IN PATIENTS WITH COMPLETE LEFT BUNDLE BRANCH BLOCK AND CHRONIC HEART FAILURE OF VARIOUS ETIOLOGIES | 2023 |
|
RU2813796C1 |
| METHOD FOR PREDICTION OF RESPONSE TO CARDIAC RESYNCHRONIZING THERAPY IN PATIENTS WITH CHRONIC HEART FAILURE | 2019 |
|
RU2721821C1 |
| METHOD FOR PREDICTING POSITIVE RESPONSE TO CARDIAC CONTRACTILITY MODULATION THERAPY IN PATIENTS WITH CHRONIC HEART FAILURE WITH REDUCED LEFT VENTRICULAR EJECTION FRACTION AND ATRIAL FIBRILLATION | 2023 |
|
RU2807230C1 |
| METHOD FOR PREDICTION OF POSITIVE RESPONSE TO CARDIO-RESYNCHRONIZING THERAPY IN PATIENTS WITH CHRONIC HEART FAILURE OF II AND III FUNCTIONAL CLASS | 2022 |
|
RU2786467C1 |
| METHOD FOR PREVENTING ANTHRACYCLINE CARDIOTOXICITY IN PATIENTS WITH BREAST CANCER | 2014 |
|
RU2546399C1 |
| METHOD FOR PREDICTING THE DEVELOPMENT OF LEFT VENTRICULAR REMODELING AFTER ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION AND HEART FAILURE USING A MULTIVARIATE REGRESSION MODEL | 2022 |
|
RU2806237C1 |
| METHOD FOR PREDICTING PROGRESSION OF ANTHRACYCLINE-INDUCED CHRONIC HEART FAILURE IN PATIENTS WITH BREAST CANCER WITHIN 24 MONTHS | 2022 |
|
RU2793672C1 |
